ArticleTheranostics2018

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.

Simon Peter Gampenrieder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.